Development of antiangiogenin peptide using a phage-displayed peptide library

Cancer Research

Volumn 57, Issue 17, 1997, Pages 3733-3740

  Gho, Yong Song ^a,b   Lee, Jung Eun ^a   Oh, Kyoung Seuk ^a   Bae, Dong Goo ^a   Chae, Chi Bom ^a  

^a Pohang University of Science and Technology (POSTECH)   (South Korea)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR;

ANGIOGENESIS; ARTICLE; CELL PROLIFERATION; DISULFIDE BOND; DNA LIBRARY; DRUG RECEPTOR BINDING; EMBRYO DEVELOPMENT; ENDOTHELIUM CELL; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MORPHOGENESIS; PEPTIDE SYNTHESIS; PHAGE DISPLAY; PRIORITY JOURNAL; TUMOR GROWTH; WOUND HEALING;

ACTINS; AMINO ACID SEQUENCE; ANGIOGENESIS INDUCING AGENTS; ANIMALS; BACTERIOPHAGES; CHICK EMBRYO; HUMANS; MOLECULAR SEQUENCE DATA; NEOVASCULARIZATION, PATHOLOGIC; PEPTIDE FRAGMENTS; PEPTIDE LIBRARY; PROTEIN ENGINEERING; PROTEINS; RIBONUCLEASE, PANCREATIC; TUMOR CELLS, CULTURED;

EID: 0000720034     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Folkman, J., and Cotran, R. S. Relation of vascular proliferation to tumor growth. Int. Rev. Exp. Pathol., 16: 207-248, 1976.
2. Folkman, J., and Klagsbrun, M. Angiogenic factors. Science (Washington DC), 235: 442-447, 1987.
3. Folkman, J. What is the evidence that tumors are angiogenesis-dependent? J. Natl. Cancer Inst. (Bethesda), 82: 4-6, 1990.
4. Nicosia, R. F., Tchao, R., and Leighton, J. Interactions between newly formed endothelial channels and carcinoma cells in plasma clot culture. Clin. Exp. Metastasis, 4: 91-104, 1986.
5. Rak, J. W., Hegmann, E. J., Lu. C., and Kerbel, R. S. Progressive loss of sensitivity to endothelium-derived growth inhibitors expressed by human melanoma cells during disease progression. J. Cell. Physiol., 159: 245-255, 1994.
6. Hamada, J., Cavanaugh, P. G., and Lotan, O. Separable growth and migration factors for large cell lymphoma cells secreted by microvascular endothelial cells derived from target organs for metastasis. Br. J. Cancer, 66: 349-354, 1992.
7. Folkman, J. Angiogenesis and breast cancer. J. Clin. Oncol., 12: 441-443, 1994.
8. Hori, A., Sasada, R., Matsutani, E., Naito, K., Sakura, Y., Fugita, T., and Kozai, Y. Suppression of solid tumor growth by immunoneutralizing monoclonal antibody against human basic fibroblast growth factor. Cancer Res., 51: 6180-6184, 1991.
9. Kim, K. J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H. S., and Ferrara, N. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo. Nature (Lond.), 362: 841-844, 1993.
10. Olson, K. A., Fett, J. W., French, T. C., Key, M. E., and Vallee, B. L. Angiogenin antagonists prevent tumor growth in vivo. Proc. Natl. Acad. Sci. USA, 92: 442-446, 1995.
11. Brooks, P. C., Montgomery, A. M. P., Rosenfeld, M., Reisfeld, R. A., Hu, T., Ilier, G., and Chresh, D. A. Integrin αvβ3 antagonists promote tumor regression by including apoptosis of angiogenic blood vessels. Cell, 79: 1157-1164, 1994.
12. Fett, J. W., Strydom, D. J., Lobb, R. R., Alderman, E. M., Bethune, J. L., Riordan, J. F., and Vallee, B. L. Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells. Biochemistry, 24: 5480-5486, 1985.
13. Montesano, R., Vassalli, J. D., Baird, A., Guillemin, R., and Orci, L. Basic fibroblast growth factor induces angiogenesis in vitro. Proc. Natl. Acad. Sci. USA, 83: 7297-7301, 1986.
14. Thomas, K. A., and Gimenez-Gallego, G. Fibroblast growth factors: broad spectrum mitogens with potent angiogenic activity. Trends Biochem. Sci., 11: 81-84, 1986.
15. Thomas, K. A., Rios-Candelore, M., Gimenez-Gallego, G., DiSalvo, J., Bennet, C., Rodkey, J., and Fitzpatrick, S. Pure brain-derived acidic fibroblast growth factor is a potent angiogenic vascular endothelial cell mitogen with sequence homology to interleukin 1. Proc. Natl. Acad. Sci. USA, 82: 6409-6413, 1985.
16. Leung, D. W., Cachianes, G., Kuang, W-J., Goeddel, D. V., and Ferrara, N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science (Washington DC), 246: 1306-1312, 1989.
17. Ferrara, N., and Henzel, W. J. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem. Biophys. Res. Commun., 161: 851-858, 1989.
18. Folkman, J. Clinical applications of research on angiogenesis. N. Engl. J. Med., 333: 1757-1763, 1995.
19. Kurachi, K., Davie, E. W., Strydom, D. J., Riordan, J. F., and Vallee, B. L. Sequence of the cDNA and gene for angiogenin, a human angiogenesis factor. Biochemistry, 24: 5494-5499, 1985.
20. Acharya, K. R., Shapiro, R., Allen, S. C., Riordan, J. F., and Vallee, B. L. Crystal structure of human angiogenin reveals the structural basis for its functional divergence from nuclease. Proc. Natl. Acad. Sci. USA, 91: 2915-2919, 1994.
21. Acharya, K. R., Shapiro, R., Riordan, J. F., and Vallee, B. L. Crystal structure of bovine angiogenin at 1.5-Å resolution. Proc. Natl. Acad. Sci. USA, 92: 2949-2953, 1995.
22. Beintema, J. J., Wietzes, P., Weickman, J. L., and Glitz, D. G. The amino acid sequence of human pancreatic ribonuclease. Anal. Biochem., 136: 48-64, 1984.
23. Shapiro, R., Weremowicz, S., Riordan, J. F., and Vallee, B. L. Ribonucleolytic activity of angiogenin: essential histidine, lysine, and arginine residues. Proc. Natl. Acad. Sci. USA, 84: 8783-8787, 1987.
24. Shapiro, R., and Vallee, B. L. Human placental ribonuclease inhibitor abolishes both angiogenic and ribonucleolytic activities of angiogenin. Proc. Natl. Acad. Sci. USA, 84: 2238-2241, 1987.
25. Shapiro, R., Fox, E. A., and Riordan, J. F. Role of lysines in human angiogenin: chemical modification and site-directed mutagenesis. Biochemistry, 28: 1726-1732, 1989.
26. Shapiro, R., and Vallee, B. L. Site-directed mutagenesis of histidine-13 and histidine-114 of human angiogenin. Alanine derivatives inhibit angiogenin-induced angiogenesis. Biochemistry, 28: 7401-7408, 1989.
27. Shapiro, R., and Vallee B. L. Identification of functional arginines in human angiogenin by site-directed mutagenesis. Biochemistry, 31: 12477-12485, 1992.
28. Hallahan, T. W., Shapiro, R., and Vallee, B. L. Dual site model for the organogenic activity of angiogenin. Proc. Natl. Acad. Sci. USA, 88: 2222-2226, 1991.
29. Bicknell, R., and Vallee, B. L. Angiogenin activates endothelial cell phospholipase C. Proc. Natl. Acad. Sci. USA, 85: 5961-5965, 1988.
30. Bicknell, R., and Vallee, B. L. Angiogenin stimulates endothelial cell prostacyclin secretion by activation of phospholipase A2. Proc. Natl. Acad. Sci. USA, 86: 1573-1577, 1989.
31. Moore, F., and Riordan, J. F. Angiogenin activates phospholipase C and elicits a rapid incorporation of fatty acid into cholesterol esters in vascular smooth muscle cells. Biochemistry, 29: 228-233, 1990.
32. Moroianu, J., and Riordan, J. F. Nuclear translocation of angiogenin in proliferating endothelial cells is essential to its angiogenic activity. Proc. Natl. Acad. Sci. USA, 91: 1677-1681, 1994.
33. Hu, G. F., Riordan, J. F., and Vallee, B. L. Angiogenin promotes invasiveness of cultured endothelial cells by stimulation of cell-associated proteolytic activities. Proc. Natl. Acad. Sci. USA, 91: 12096-12100, 1994.
34. Jimi, S. I., Ito, K. I., Kohno, K., Ono, M., Kuwano, M., Itagaki, Y., and Ishikawa, H. Modulation by bovine angiogenin of tabular morphogenesis and expression of plasminogen activator in bovine endothelial cells. Biochem. Biophys. Res. Commun., 211: 476-483, 1995.
35. Hu, G. F., Chang, S. I., Riordan, J. F., and Vallee, B. L. An angiogenin-binding protein from endothelial cells. Proc. Natl. Acad. Sci. USA, 88: 2227-2231, 1991.
36. Hu, G. F., Strydom, D. J., Fett, J. W., Riordan, J. F., and Vallee, B. L. Actin is a binding protein for angiogenin. Proc. Natl. Acad. Sci. USA, 90: 1217-1221, 1993.
37. Harper, J. W., and Vallee, B. L. A covalent angiogenin/ribonuclease hybrid with a fourth disulfide bond generated by regional mutagenesis. Biochemistry, 28: 1875-1884, 1989.
38. Raines, R. T., Toscano, M. P., Nierengarten, D. M., Ha, J. H., and Auerbach, R. Replacing a surface loop endows ribonuclease A with angiogenic activity. J. Biol. Chem., 270: 17180-17184, 1995.
39. Cwirla, S. E., Peters, E. A., Barret, R. W., and Dower, W. J. Peptides on phage: a vast library of peptides for identifying ligands. Proc. Natl. Acad. Sci. USA, 87: 6378-6382, 1990.
40. Scott, J. K., and Smith, G. P. Searching for peptide ligands with an epitope library. Science (Washington DC), 249: 386-390, 1990.
41. Pasqualini, R., Koivunen, E., and Ruoslahti, E. α-v integrins as receptors for tumor targeting by circulating ligands. Nat. Biotechnol., 15: 542-546, 1997.
42. Parmley, S. F., and Smith, G. P. Antibody-selectable filamentous fd phage vectors: affinity purification of target genes. Gene, 73: 305-318, 1988.
43. Sanger, F., Nicklen, S., and Coulson, A. R. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA, 74: 5463-5467, 1977.
44. Rybak, S. M., Auld, D. S., St. Clair, D. K., Yao, Q. Z., and Fett, J. W. C-terminal angiogenin peptides inhibit the biological and enzymatic activities of angiogenin. Biochem. Biophys. Res. Commun., 162: 535-543, 1989.
45. Bar-Shavit, R., Sabbah, V., Lampugnani, M. G., Marchisio, P. C., Fenton, J. W., II, Vloddavsky, I., and Dejana, E. An Arg-Gly-Asp sequence within thrombin promotes endothelial cell adhesion. J. Cell Biol., 12: 335-344, 1991.
46. Soncin, F. Angiogenin supports endothelial and fibroblast cell adhesion. Proc. Natl. Acad. Sci. USA, 89: 2232-2236, 1992.
47. Soncin, F., Shapiro, R., and Fett, J. W. A cell-surface proteoglycan mediates human adenocarcinoma HT-29 cell adhesion to human angiogenin. J. Biol. Chem., 269: 8999-9005, 1994.
48. O'Neil, K. T., Hoess, R. H., Jackson, S. A., Ramachandran, N. S., Mousa, S. A., and DeGrado, W. F. Identification of novel peptide antagonists for GP IIb/IIIa from a conformationally constrained phage peptide library. Proteins Struct. Funct. Genet., 14: 509-515, 1992.
49. Yayon, A., Aviezer, D., Safran, M., Gross, J. L., Heldman, Y., Cabilly, S., Givol, D., and Katchalski-Katzir, E. Isolation of peptides that inhibit binding of basic fibroblast growth factor to its receptor from a random phage-epitope library. Proc. Natl. Acad. Sci. USA, 90: 10643-10647, 1993.
50. Olson, K. A., French, T. C., Vallee, B. L., and Fett, W. A monoclonal antibody to human angiogenin suppress tumor growth in athymic mice. Cancer Res., 54: 4576-4579, 1994.
51. Waldman, T. A. Monoclonal antibodies in diagnosis and therapy. Science (Washington DC), 252: 1657-1662, 1991.
52. Lee, W. M., and Galbraith, R. M. The extracellular actin-scavenger system and actin toxicity. N. Engl. J. Med., 326: 1335-1341, 1992.
53. Haddad, J. G., Harper, K. D., Guoth, M., Pietra, G. G., and Sanger, J. W. Angiopathic consequences of saturating the plasma scavenger system for actin. Proc. Natl. Acad. Sci. USA, 87: 1382-1385, 1990.